A Phase 4 interventional study of Polyethylene glycol and Oral sodium phosphate solution in Colon Cleansing, sponsored by Bausch Health Americas, Inc.. Completed at 18 sites in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2018-01-18.
Sponsored by Bausch Health Americas, Inc. (part of Bausch Health Companies Inc.) · Phase 4, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to compare the safety and efficacy of OsmoPrep tablets versus HalfLytely and Bisacodyl Tablet Bowel Prep Kit in subjects who are undergoing colonoscopy.
Bausch Health Americas, Inc. is the lead sponsor of 213 studies on the registry; 7 are open to participants now.
Of its 25 completed or terminated interventional studies of FDA-regulated products, 18 (72%) have results posted.
First submitted after Bausch Health Americas, Inc. became part of Bausch Health Companies Inc..
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Biopsy and archival tissue
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: Oral sodium phosphate solution
Drug: Polyethylene glycol
HalfLytely and Bisacodyl Tablet Bowel Prep Kit, administered as 1 bisacodyl tablet followed by HalfLytely oral solution in a total liquid volume of approximately 2 L
OsmoPrep tablets (48 g), administered as 32 total tablets in a total liquid volume of approximately 2 L
Distribution of the Overall Colon-cleansing Scale in Each Treatment Group.
Time frame: 6 months
| Milestone | OsmoPrep Tablets | HalfLytely and Bisacodyl Tablet |
|---|---|---|
| Started | 1041 | 1051 |
| Completed | 1041 | 1051 |
| Not completed | 0 | 0 |
| Participants | OsmoPrep Tablets | HalfLytely and Bisacodyl Tablet |
|---|---|---|
| Excellent | 618 | 243 |
| Good | 275 | 423 |
| Fair | 116 | 286 |
| Inadequate | 23 | 88 |
Non-serious events are listed at a 1% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| OsmoPrep Tablets | — | 20/1,041 (1.9%) | 443/1,041 (42.6%) |
| HalfLytely and Bisacodyl Tablet | — | 19/1,051 (1.8%) | 352/1,051 (33.5%) |
| Event | OsmoPrep Tablets | HalfLytely and Bisacodyl Tablet |
|---|---|---|
| Renal cell carcinomaNeoplasms benign, malignant and unspecified (incl cysts and polyps) | 2/1041 | 0/1051 |
| Atrial fibrillationCardiac disorders | 1/1041 | 2/1051 |
| ANAEMIABlood and lymphatic system disorders | 1/1041 | 0/1051 |
| Angina unstableCardiac disorders | 1/1041 | 0/1051 |
| Coronary artery diseaseCardiac disorders | 1/1041 | 0/1051 |
| GoitreEndocrine disorders | 1/1041 | 0/1051 |
| Colitis ischaemicGastrointestinal disorders | 1/1041 | 0/1051 |
| Colitis ulcerativeGastrointestinal disorders | 1/1041 | 0/1051 |
| Colonic FistulaGastrointestinal disorders | 1/1041 | 0/1051 |
| IleusGastrointestinal disorders | 1/1041 | 0/1051 |
| Event | OsmoPrep Tablets | HalfLytely and Bisacodyl Tablet |
|---|---|---|
| HyperphosphataemiaMetabolism and nutrition disorders | 136/1041 | 0/1051 |
| NauseaGastrointestinal disorders | 42/1041 | 50/1051 |
| VomitingGastrointestinal disorders | 23/1041 | 45/1051 |
| Urinary tract infectionInfections and infestations | 34/1041 | 38/1051 |
| HypokalaemiaMetabolism and nutrition disorders | 33/1041 | 11/1051 |
| Upper respiratory tract infectionInfections and infestations | 24/1041 | 25/1051 |
| GastritisGastrointestinal disorders | 21/1041 | 11/1051 |
| Abdominal painGastrointestinal disorders | 12/1041 | 21/1051 |
| Back painMusculoskeletal and connective tissue disorders | 13/1041 | 21/1051 |
| HeadacheNervous system disorders | 20/1041 | 16/1051 |
| Age, Customized(Participants) | OsmoPrep Tablets | HalfLytely and Bisacodyl Tablet | Total |
|---|---|---|---|
| <65 | 906 | 932 | 1838 |
| >=65 | 135 | 119 | 254 |
| Sex: Female, Male(Participants) | OsmoPrep Tablets | HalfLytely and Bisacodyl Tablet | Total |
|---|---|---|---|
| Female | 616 | 645 | 1261 |
| Male | 425 | 406 | 831 |
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2011 to primary completion in Mar 2014, 29 months.
Results were first posted in Jan 2018, 3 years 10 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Polyethylene Glycols · Sodium phosphate
Bausch Health Americas, Inc. →